An inhibitor, 9-amino-1,2,3,4-tetra hydroacridine (tacrine), is a reversible inhibitor of esterases. The reversible inhibition of the enzyme activity is thought to be examined after separation and immobilization of the enzyme under non-denaturing conditions. Hydrolytic changes of phosphatidylcholine by carboxylesterase were obtained using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry after the esterase was separated by non-denaturing two-dimensional electrophoresis, was immobilized to membranes and was stained by Ponceau S. The changes were inhibited after the enzyme on the membrane was treated by tacrine. Furthermore, the hydrolytic activity of the esterase was recovered after the inhibitor was washed with aspartic acid solution. These results indicate that the phosphatidylcholine hydrolysis activity of the isolated and immobilized enzyme is reversibly inhibited under non-denaturing conditions. Furthermore, this method can be developed to the production of an enzyme reactor able to regulate amounts of lipids.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
- MALDI-TOF MS:
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
Coomassie brilliant blue
Marquis, J. K. (1990). Biochemical Pharmacology, 40, 1071–1076.
Bencharit, S., Morton, C. L., Hyatt, J. L., Kuhn, P., Danks, M. K., Potter, P. M., et al. (2003). Chemistry & Biology, 10, 341–349.
Smith, C. P., Bores, G. M., Petko, W., Li, M., Selk, D. E., Rush, D. K., et al. (1997). Journal of Phamacology and Experimental Therapeutics, 280, 710–720.
Lund-Pero, M., Jeppson, B., Arneklo-Nobin, B., Sjorgen, H. O., Holmgren, K., & Pero, R. W. (1994). Clinica Chimica Acta, 224, 9–20.
Shimazaki, Y., & Watanabe, S. (2008). Clinica Chimica Acta, 390, 145–147.
Shimazaki, Y., & Kuroda, T. (2009). Biotechnology Letters, 31, 1545–1549.
Shimazaki, Y., Sugawara, Y., Ohtsuka, Y., & Manabe, T. (2003). Proteomics, 3, 2002–2007.
Shimazaki, Y., & Sakikawa, T. (2010). Protein and Peptide Letters, 17, 1048–1052.
Zschornig, O., Pietsch, M., Suß, R., Schiller, J., & Gutschow, M. (2005). Journal of Lipid Research, 46, 803–811.
Sathishkumar, M., Jayabalan, R., Mun, S. P., & Yun, S. E. (2010). Bioresource Technology, 101, 7834–7840.
He, P., Davies, J., Greenway, G., & Haswell, S. J. (2010). Analytica Chimica Acta, 659, 9–14.
About this article
Cite this article
Sakikawa, T., Shimazaki, Y. Reversible Inhibition of Esterase Activity After Separation and Immobilization. Appl Biochem Biotechnol 165, 69–74 (2011). https://doi.org/10.1007/s12010-011-9233-z
- Ponceau S
- MALDI-TOF MS